Dolores Shoback
Overview
Explore the profile of Dolores Shoback including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
2072
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Faiq S, Lavelle K, Hu T, Shoback D, Ku G
BMC Endocr Disord
. 2023 Jun;
23(1):133.
PMID: 37328745
Background: In the acute setting, PTH-independent hypercalcemia is typically treated with anti-resorptive agents such as zoledronic acid or denosumab. When these agents are no longer able to control hypercalcemia, several...
2.
Shoback D, Rosen C, Black D, Cheung A, Murad M, Eastell R
J Clin Endocrinol Metab
. 2020 Feb;
105(3).
PMID: 32068863
Objective: The objective is to provide an update of the 2019 Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Clinical Practice Guideline for the pharmacological management of osteoporosis...
3.
Wentworth K, Shoback D
JAMA Intern Med
. 2019 Jul;
179(9):1227-1229.
PMID: 31305872
No abstract available.
4.
Eastell R, Rosen C, Black D, Cheung A, Murad M, Shoback D
J Clin Endocrinol Metab
. 2019 Mar;
104(5):1595-1622.
PMID: 30907953
Objective: The objective is to formulate clinical practice guidelines for the pharmacological management of osteoporosis in postmenopausal women. Conclusions: Evidence from clinical trials and insights from clinical experience with pharmacologic...
5.
Cheng C, Shoback D
Curr Osteoporos Rep
. 2019 Jan;
17(1):36-47.
PMID: 30671884
Purpose Of Review: Substantial advances have been made in understanding the biological basis of fracture healing. Yet, it is unclear whether the presence of osteoporosis or prior or current osteoporosis...
6.
Kim S, Peluso M, Wang Y, Bikle D, Shoback D, Kim S
Bone Rep
. 2019 Jan;
10:100194.
PMID: 30627599
Hypercalcemia in HIV patients has been previously reported, but 1,25-(OH) vitamin D-mediated hypercalcemia, due to increased activity of extrarenal 1-alpha hydroxylase, is rarely described with HIV-related infections or malignancies. We...
7.
Babey M, Brandi M, Shoback D
Endocrinol Metab Clin North Am
. 2018 Nov;
47(4):889-900.
PMID: 30390820
Conventional therapy of hypoparathyroidism consists of oral calcium and either activated vitamin D or vitamin D supplements at varying doses. Although adjusting dosing of calcium and/or activated vitamin D or...
8.
9.
Brandi M, Bilezikian J, Shoback D, Bouillon R, Clarke B, Thakker R, et al.
J Clin Endocrinol Metab
. 2016 Mar;
101(6):2273-83.
PMID: 26943719
Objective: Hypoparathyroidism is a rare disorder characterized by hypocalcemia and absent or deficient PTH. This report presents a summary of current information about epidemiology, presentation, diagnosis, clinical features, and management...
10.
Santa Maria C, Cheng Z, Li A, Wang J, Shoback D, Tu C, et al.
Semin Cell Dev Biol
. 2015 Dec;
49:11-23.
PMID: 26688334
Parathyroid hormone (PTH)-related peptide (PTHrP) controls the pace of pre- and post-natal growth plate development by activating the PTH1R in chondrocytes, while PTH maintains mineral and skeletal homeostasis by modulating...